Logo
amols shinde @go_66597b1773076
2 months ago
#Autoinjectors market was valued at USD 1,100 million in 2022 and is expected to reach USD 2,491 million by 2033, growing at a CAGR of 13.5%. Autoinjectors, used for easy self-administration of medication, are gaining traction in treating chronic conditions like rheumatoid arthritis, multiple sclerosis, and diabetes.

Read More: https://wemarketresearch.c...

#healthcareinnovation #MedicalDevices #ChronicDiseaseCare #SelfInjection #PharmaTrends
05:13 AM - Apr 04, 2025 (UTC)
Vishal Chavan @go_67beefe85aabe
29 days ago
Parenteral Nutrition Market is driven by the rising prevalence of chronic diseases and malnutrition
The growing Parenteral Nutrition Market Demand is driven by the increasing prevalence of chronic diseases, such as cancer, gastrointestinal disorders, and malnutrition, which can impair the body's ability to absorb nutrients through the digestive system.
The parenteral nutrition market encompasses a range of intravenous feeding solutions and equipment designed to provide essential nutrients to patients who cannot consume or absorb adequate nutrition through the gastrointestinal tract.

Parenteral Nutrition Market

https://www.coherentmarket...

#ParenteralNutrition , #healthcareinnovation , #ClinicalNutrition , #ChronicDiseaseCare , #GlobalHealthTrends , #CoherentMarketInsights .
08:39 AM - Apr 22, 2025 (UTC)
Vishal Chavan @go_67beefe85aabe
15 days ago
Hypercalcemia Treatment Market Will Grow at Highest Pace Owing to Biotech Advances

The growing Hypercalcemia Treatment Market Growth is fueled by an aging global population, rising prevalence of chronic kidney disease, and increasing incidence of malignancy‐related calcium dysregulation. As life expectancy increases, more patients present with secondary hyperparathyroidism, necessitating long term management strategies.
Hypercalcemia treatment encompasses a range of pharmaceutical agents and therapeutic protocols designed to restore calcium homeostasis in patients presenting elevated serum calcium levels. Products include calcimimetics such as cinacalcet, bisphosphonates, monoclonal antibodies targeting parathyroid hormone and emerging gene‐based therapies.

Hypercalcemia Treatment Market

https://www.coherentmarket...

#HypercalcemiaTreatment ,#BiopharmaInnovation,#ChronicDiseaseCare,#AsiaPacificHealthcare,#CoherentmarketInsights.
09:56 AM - May 06, 2025 (UTC)

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.